Join
Live feed
·
PRReleasevia Quantisnow
Eyegate Pharmaceuticals, Inc. logo

EyeGate Announces Closing of $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

ByQuantisnow·Wall Street's wire, on your screen.
EYEG· Eyegate Pharmaceuticals, Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEG (Eyegate Pharmaceuticals, Inc.) and more on Quantisnow.